Applying Clinical Trial Data in mCSPC Care
Steve Jackson, PharmD
Jahan Aghalar, MD
Ulka Vaishampayan, MD
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
August 20, 2026
02:30 PM - 03:30 PM ET
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026 Houston, Texas
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Rising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Nisha Joseph, MD
EHA 2026: Long-Term Zanubrutinib Outcomes
Alessandra Tedeschi, MD
Targeting PTEN: Why It Matters
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Molecular Profiling in mHSPC: Informing Treatment Selection
Addressing Oncology-Related Infertility Through Collaborative Care
Irene Su, MD, MSCE
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Nicolas Girard, MD
Louise Lim, MD
Jacob Sands, MD
Stephanie McDonald, MSN, FNP-BC, AOCNP
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Lyudmila A. Bazhenova, MD
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.